Generation Bio Cash on Hand 2020-2023 | GBIO
Generation Bio cash on hand from 2020 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Generation Bio Annual Cash on Hand
(Millions of US $) |
| 2023 |
$264 |
| 2022 |
$279 |
| 2021 |
$375 |
| 2020 |
$262 |
| 2019 |
$15 |
Generation Bio Quarterly Cash on Hand
(Millions of US $) |
| 2023-12-31 |
$264 |
| 2023-09-30 |
$291 |
| 2023-06-30 |
$314 |
| 2023-03-31 |
$289 |
| 2022-12-31 |
$279 |
| 2022-09-30 |
$301 |
| 2022-06-30 |
$312 |
| 2022-03-31 |
$337 |
| 2021-12-31 |
$375 |
| 2021-09-30 |
$398 |
| 2021-06-30 |
$425 |
| 2021-03-31 |
$451 |
| 2020-12-31 |
$262 |
| 2020-09-30 |
$280 |
| 2020-06-30 |
$301 |
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.188B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
